Clinical Trials · NCT06824818

Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients

Name: Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

RecruitingN/AGonadorelin

Phase: N/A
Recruitment status: Recruiting
Sponsor: University of Chicago
Enrollment: 155
Start date: Jun 2026
Locations: 2 sites, United States
Primary endpoint: feasibility of stopping LHRH agonist therapy

View Gonadorelin compound reference